18 June 2013
Keywords: vegf, trap, maintains, gain, visual, acuity, germany
Article | 12 May 2008
Germany's Bayer HealthCare AG and USA-based Regeneron Pharmaceuticals say that their VEGF Trap-Eye dosed on an as-needed dosing schedule
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 May 2008
19 May 2008
© 2013 thepharmaletter.com